Private Practice, Milan, Italy.
University of Milan, Via festa del perdono, 7, 20122, Milan, Italy.
Aesthetic Plast Surg. 2024 Oct;48(20):4144-4155. doi: 10.1007/s00266-024-03917-2. Epub 2024 Mar 11.
The goals of mastopexy differ significantly from those of augmentation mammoplasty. Mastopexy is designed to lift and reshape the breasts, while augmentation mammoplasty is designed to increase the volume of the breasts. This conflict causes that one-stage augmentation mastopexies showed a revision rate from 8.7 to 23.2%. The aim of our study is to present some technical refinements for reducing the risk of implant exposure and reoperation.
We designed a retrospective matched cohort study, including 216 consecutive patients, undergone augmentation mastopexy between January 2013 and December 2022. We divided them in two groups: Group A undergone an inverted-T superomedial pedicled augmentation mastopexy and Group B undergone our inverted-T modified augmentation mastopexy. The groups were matched for clinical and surgical variables, with the surgical technique the only difference between the two.
Complications were registered in ten patients (9.3%) in Group A (two wound breakdowns at T with implant exposure and eight wound dehiscences), six of which required surgical revision. In contrast, only three patients (2.8%) in Group B reported a complication, which was wound dehiscence without implant exposure in all cases. None of the dehiscence required surgical revision. The difference between complication and revision rates was statistically significant.
Separating the implant and the mastopexy dissection planes reduces the implant exposure and the reoperation rate in one-stage augmentation mastopexy.
This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors https://link.springer.com/journal/00266 .
乳房上提术的目标与隆胸术有很大的不同。乳房上提术旨在提升和重塑乳房，而隆胸术旨在增加乳房的体积。这种冲突导致一期隆胸乳房上提术的修复率从 8.7%到 23.2%不等。我们的研究旨在提出一些技术改进措施，以降低假体暴露和再次手术的风险。
我们设计了一项回顾性匹配队列研究，纳入了 216 例连续接受隆胸乳房上提术的患者，这些患者均在 2013 年 1 月至 2022 年 12 月间接受了手术。我们将他们分为两组：A 组接受倒 T 型超内侧蒂隆胸乳房上提术，B 组接受我们的倒 T 型改良隆胸乳房上提术。两组在临床和手术变量方面进行了匹配，唯一的区别是手术技术。
A 组有 10 例（9.3%）患者发生并发症（两处 T 型切口的伤口裂开伴假体暴露，8 例伤口裂开），其中 6 例需要手术修复。相比之下，B 组只有 3 例（2.8%）患者报告了并发症，所有病例均为无假体暴露的伤口裂开。无一例裂开需要手术修复。并发症和修复率之间的差异具有统计学意义。
分离假体和乳房上提术的分离平面可降低一期隆胸乳房上提术的假体暴露和再次手术率。
证据水平 III：本杂志要求作者为每篇文章分配一个证据水平。如需详细了解这些循证医学评级，请参考目录或在线作者指南 https://link.springer.com/journal/00266 。
